Overview
Sporadic hyperekplexia is a rare neurological disorder characterized by exaggerated startle responses and hypertonia in neonates, often improving with age. It primarily results from mutations affecting glycinergic neurotransmission, particularly in the glycine receptor (GlyR) α1 and β subunits 12.Diagnosis
Clinical Presentation: Exaggerated startle reaction to auditory, somatosensory, and visual stimuli, and generalized flexor spasms in response to glabellar tap 12.
Family History: May reveal autosomal recessive or dominant inheritance patterns 23.
Genetic Testing: Mutation analysis of GLRA1 and other glycinergic pathway genes (e.g., GlyT2, gephyrin, collybistin) recommended 12.
CSF Analysis: Low cerebrospinal fluid concentration of free GABA may be observed, though not diagnostic on its own 4.Management
First-Line Treatment: Clonazepam is the primary pharmacological intervention, often leading to significant but incomplete symptom relief 24.
Adjunctive Therapies: Additional supportive care may include physical therapy to manage hypertonia and developmental delays 3.Special Populations
Pediatrics: Transient hyperekplexia with persistent abnormal startle responses noted in early childhood, often resolving with normal psychomotor development 3.
Genetic Considerations: Close consanguineous marriages can increase the risk of familial cases with severe brain malformations 1.Key Recommendations
Genetic Testing for GLRA1 Mutations: Essential for confirming diagnosis and understanding inheritance patterns (Evidence: Strong 2).
Initiate Clonazepam for Symptom Management: Effective for reducing startle responses and hypertonia (Evidence: Moderate 24).
Monitor Developmental Outcomes: Regular assessments are crucial in pediatric patients to address any developmental delays (Evidence: Expert opinion 3).References
1 Seidahmed MZ, Salih MA, Abdulbasit OB, Shaheed M, Al Hussein K, Miqdad AM et al.. A novel syndrome of lethal familial hyperekplexia associated with brain malformation. BMC neurology 2012. link
2 Andrew M, Owen MJ. Hyperekplexia: abnormal startle response due to glycine receptor mutations. The British journal of psychiatry : the journal of mental science 1997. link
3 Pascotto A, Coppola G. Neonatal hyperekplexia: a case report. Epilepsia 1992. link
4 Dubowitz LM, Bouza H, Hird MF, Jaeken J. Low cerebrospinal fluid concentration of free gamma-aminobutyric acid in startle disease. Lancet (London, England) 1992. link90398-m)